Autoimmune and neuropsychiatric phenotypes in a Mecp2 transgenic mouse model on C57BL/6 background
Authors:
Open Access
- 8 March 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1370254
Abstract
Introduction: Systemic Lupus Erythematosus (SLE) impacts the central nervous system (CNS), leading to severe neurological and psychiatric manifestations known as neuropsychiatric lupus (NPSLE). The complexity and heterogeneity of clinical presentations of NPSLE impede direct investigation of disease etiology in patients. The limitations of existing mouse models developed for NPSLE obstruct a comprehensive understanding of this disease. Hence, the identification of a robust mouse model of NPSLE is desirable.Methods: C57BL/6 mice transgenic for human MeCP2 (B6.Mecp2Tg1) were phenotyped, including autoantibody profiling through antigen array, analysis of cellularity and activation of splenic immune cells through flow cytometry, and measurement of proteinuria. Behavioral tests were conducted to explore their neuropsychiatric functions. Immunofluorescence analyses were used to reveal altered neurogenesis and brain inflammation. Various signaling molecules implicated in lupus pathogenesis were examined using western blotting.Results: B6.Mecp2Tg1 exhibits elevated proteinuria and an overall increase in autoantibodies, particularly in female B6.Mecp2Tg1 mice. An increase in CD3+CD4+ T cells in the transgenic mice was observed, along with activated germinal center cells and activated CD11b+F4/80+ macrophages. Moreover, the transgenic mice displayed reduced locomotor activity, heightened anxiety and depression, and impaired short-term memory. Immunofluorescence analysis revealed IgG deposition and immune cell infiltration in the kidneys and brains of transgenic mice, as well as altered neurogenesis, activated microglia, and compromised blood-brain barrier (BBB). Additionally, protein levels of various key signaling molecules were found to be differentially modulated upon MeCP2 overexpression, including GFAP, BDNF, Albumin, NCoR1, mTOR, and NLRP3.Discussion: Collectively, this work demonstrates that B6.Mecp2Tg1 mice exhibit lupus-like phenotypes as well as robust CNS dysfunctions, suggesting its utility as a new animal model for NPSLE.Keywords
Funding Information
- National Institutes of Health
This publication has 80 references indexed in Scilit:
- Choroid Plexus–Infiltrating T Cells as Drivers of Murine Neuropsychiatric LupusArthritis & Rheumatology, 2022
- Discovery of IgG4 Anti‐Gliadin Autoantibody as a Potential Biomarker of Psoriasis Using an Autoantigen ArrayProteomics – Clinical Applications, 2019
- Protein Arrays II: Antigen Arrays2017
- MECP2duplication: Possible cause of severe phenotype in femalesAmerican Journal of Medical Genetics Part A, 2014
- The MECP2 duplication syndromeAmerican Journal of Medical Genetics Part A, 2010
- Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosusArthritis & Rheumatism, 2009
- Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvementArthritis & Rheumatism, 2003
- Associations between meCP2 mutations, x‐chromosome inactivation, and phenotypeMental Retardation and Developmental Disabilities Research Reviews, 2002
- Anxiety Behavior, Exploratory Behavior, and Activity in NZB × NZW F1 Hybrid Mice: Role of Genotype and Autoimmune Disease ProgressionBrain, Behavior, and Immunity, 1996
- Evaluation of memory, learning ability, and clinical neurologic function in pathogen‐free mice with systemic lupus erythematosusArthritis & Rheumatism, 1994